SUBSCRIBE
SUBSCRIBE
News   Drug Development

Lexicon Pharmaceuticals, Inc. Diabetes Drug Trial Shows Promise

September 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- Lexicon Pharmaceuticals Inc said its experimental diabetes drug proved to be safe and well tolerated in an early stage study, driving its shares to more than double in value.
Clinical research Phase I
MORE ON THIS TOPIC
Wood block with healthcare medical icon on blue background. Health care insurance concept
Infectious disease
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25
July 15, 2025
 · 
4 min read
 · 
Tristan Manalac
Contemporary art collage. Conceptual design with young woman, motivated employee running forward to reach goal, professional success. Concept of business, career development, achievement
Obesity
Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III
July 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
3d rendering medical heart in yellow background
Cardiovascular disease
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
July 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky